Abstract
A regio- and stereoselective method has been developed for the synthesis of novel fluorinated 2-aminocyclohexanecarboxylic acid derivatives with the fluorine attached to position 4 of the ring. The synthesis starts from either cis- or trans-β-aminocyclohex-4-enecarboxylic acids and involves regio- and stereoselective transformation of the ring C–C double bond through iodooxazine formation and hydroxylation, followed by hydroxy–fluorine or oxo–fluorine exchange.
Keywords: amino acids, epoxidation, fluorination, hydroxylation, stereoselective reaction
Introduction
Fluorine chemistry is an expanding area of research that has generated increasing interest in pharmaceutical and medicinal chemistry in recent years because of its considerable impact in drug discovery. There is currently extensive research activity in synthetic chemistry for the preparation of various biologically active fluorinated products [1–10].
Of special interest among such materials are the fluorinated amino acids, which in most cases exhibit higher bioactivities than the nonfluorinated counterparts. The fluorinated α- or acyclic β-amino acids have acquired significance as antibacterial or antifungal agents, enzyme inhibitors or as antitumoral compounds. Introduction of a fluorinated amino acid into a peptide may generate specific protein–ligand or protein–protein interactions, thereby determining thermal or metabolic stabilities, which is of great importance in peptide-based drug research [11–35]. These changes in properties may be more appreciable in the case of peptide oligomers formed from conformationally restricted fluorinated amino acids. Although cyclic β-amino acids are of major interest in pharmaceutical chemistry and in peptide research [36–60], only a relatively small number of fluorinated derivatives of this class of compounds have been synthesized so far [61–70].
Results and Discussion
We recently developed a synthetic method for the regio- and stereoselective introduction of a fluorine atom onto the skeleton of a β-aminocyclohexanecarboxylic acid. The synthesis starts from the Boc-protected 2-aminocyclohex-4-enecarboxylic acid or 2-aminocyclohex-3-enecarboxylic acid and involves ring C–C bond transformation by regio- and stereoselective hydroxylation via iodolactonization, followed by hydroxy–fluorine exchange. This protocol was applied to synthesize fluorinated β-aminocyclohexane scaffolds with the fluorine atom on either position 3 or 5 of the ring. Whereas the procedure is a convenient economical route to fluorinated cyclohexane or cyclohexene β-amino acids, it did not allow extension to the synthesis of similar derivatives with the fluorine atom on position 4.
During our work performed to fill this gap, we have developed a synthetic procedure for gaining access to fluorinated β-aminocyclohexanecarboxylic acids.
This synthesis starts from ethyl cis-2-aminocyclohex-4-enecarboxylate 1 [57] and follows two different strategies. One is based on regio- and stereoselective hydroxylation via iodooxazine formation, followed by fluorination, while the other includes stereoselective epoxidation and regioselective oxirane opening, followed by hydroxy–fluorine exchange. In the former protocol, amino ester 1 is treated with KI/I2 in H2O/CH2Cl2, which affords iodooxazinone derivative 2 stereo- and regioselectively (Scheme 1, Figure 1). Next, compound 2 is transformed to 3 by amide N-Boc protection with Boc2O and 4-dimethylaminopyridine (DMAP) in THF. Removal of the iodine from the cyclohexane skeleton in 3 is accomplished under reductive conditions. On treatment with n-Bu3SnH in the presence of a catalytic amount of azobisisobutyronitrile (AIBN) in dichloromethane under reflux, 3 undergoes deiodination to give ester 4 in 70% yield. Oxazinone 4 is then subjected to heterocycle ring opening with NaOEt in EtOH at 0 °C to furnish all-cis hydroxylated amino ester 5 with the hydroxy group on position 4 of the skeleton (Scheme 1, Figure 2).
Scheme 1.
Synthesis of all-cis ethyl 4-hydroxylated β-aminocyclohexanecarboxylate 5.
Figure 1.
ORTEP diagram of iodooxazinone 2. Thermal ellipsoids have been drawn at the 20 % probability level.
Figure 2.
ORTEP diagram of hydroxylated amino ester 5. Thermal ellipsoids have been drawn at the 20% probability level.
Hydroxylated amino ester 5 was also prepared via the alternative route involving stereoselective epoxidation. Cyclohexene β-amino ester 1 underwent C–C double bond oxidation with 3-chloroperbenzoic acid (MCPBA) to afford epoxy amino ester 6 cis-diastereoselectively [57] (Scheme 1). Opening of the oxirane ring in 6 with NaBH4 in EtOH at 70 °C proceeded regioselectively, providing exclusively amino ester 5 with the hydroxy function on position 4 (for analogous transformations, see reference [60]).
Hydroxylated amino ester 5 was next further used as a key compound for the synthesis of fluorinated target materials. A fluorine atom was introduced by hydroxy–fluorine exchange with bis(dimethoxyethylaminosulfur trifluoride) (Deoxo-Fluor®) reagent. The reaction was carried out under different experimental conditions, with variation of the temperature (−40 °C, 0 °C or 20 °C) and the solvent (toluene, CH2Cl2 or THF). Finally, it was found that hydroxylated amino ester 5 underwent inversion on reaction with a 50% Deoxo-Fluor toluene solution in CH2Cl2 at 0 °C [68–69] to give monofluorinated cyclohexane amino ester 7 in 32% yield (Scheme 2). This rather modest yield is attributed to the relatively large amount of elimination materials (40% overall). In continuation, the geminal difluorinated β-aminocyclohexanecarboxylic acid derivative with the fluorine atoms on position 4 was efficiently synthesized. Oxidation of the hydroxy group of amino ester 5 with pyridinium chlorochromate (PCC) in CH2Cl2 yielded the corresponding oxo-group-containing amino ester 8, which was then converted with Deoxo-Fluor in CH2Cl2 at 0 °C to the corresponding geminal difluoro amino ester 9 in good yield (Scheme 2).
Scheme 2.
Syntheses of fluorinated amino esters 7 and 9.
The synthetic route presented above could be extended to the preparation of other 4-fluorinated cyclohexane amino acid derivatives, stereoisomers of 7 or 9. Ethyl trans-2-aminocyclohex-4-enecarboxylate 10 [57] was analogously transformed to its cis counterpart through regio- and stereoselective iodooxazine formation with KI/I2 to give compound 11 (Scheme 3). N-Protection of 11, followed by reductive deiodination, proceeded via 12 (Figure 3) to afford ester 13. Opening of the heterocyclic ring with NaOEt in EtOH at 0 °C furnished 4-hydroxylated amino ester 14, a stereoisomer of 5 (Scheme 3, Figure 4).
Scheme 3.
Synthesis of ethyl 4-hydroxy-β-aminocyclohexanecarboxylate 14.
Figure 3.
ORTEP diagram of iodooxazinone derivative 12. Thermal ellipsoids have been drawn at the 20% probability level.
Figure 4.
ORTEP diagram of hydroxylated amino ester 14. The water molecule oxygen atom O4 is situated on the twofold axis with a population parameter of 0.6. Thermal ellipsoids have been drawn at the 20% probability level.
It is noteworthy that in this latter case hydroxylated amino ester 14 could not be prepared by the alternative diastereoselective epoxidation and regioselective oxirane opening strategy: according to our previous results, the opening of epoxide 15 derived from 10 proceeded via a trans-diaxial chair conformation with the nucleophile attack on C4, thereby providing the 5-hydroxylated derivative [57,60].
Next, hydroxylated cyclohexane amino ester 14 was converted with Deoxo-Fluor in CH2Cl2 at 0 °C to 4-fluorinated ethyl β-aminocyclohexanecarboxylate 16, a stereoisomer of 7. Unfortunately, the formation of a substantial amount of a mixture of elimination material could again not be avoided. When subjected to oxidation with PCC, amino ester 14 gave the corresponding oxo ester 17, treatment of which with Deoxo-Fluor in CH2Cl2 at 0 °C provided geminal 4,4-difluorinated cyclohexane amino ester 18, a stereoisomer of 9 (Scheme 4).
Scheme 4.
Syntheses of fluorinated amino esters 16 and 18.
Conclusion
In conclusion, a simple and convenient procedure has been developed for the introduction of one or two fluorine atoms onto the skeleton of either cis- or trans-β-aminocyclohexanecarboxylates. The synthetic concept involves regio- and stereoselective hydroxylation via iodooxazine formation, followed by hydroxy–fluorine or oxo–fluorine exchange.
Supporting Information
Experimental procedures and characterization of compounds.
Acknowledgments
We are grateful to the Hungarian Research Foundation (OTKA No. NK81371 and K100530) and TAMOP-4.2.2.A-II/1/KONV-2012-0052 for financial support.
References
- 1.Gouverneur V, Müller K, editors. Fluorine in Pharmaceutical and Medicinal Chemistry: From Biophysical Aspects to Clinical Applications. London: Imperial College Press; 2012. [Google Scholar]
- 2.Hagmann W K. J Med Chem. 2008;51:4359. doi: 10.1021/jm800219f. [DOI] [PubMed] [Google Scholar]
- 3.Isanbor C, O’Hagan D. J Fluorine Chem. 2006;127:303. doi: 10.1016/j.jfluchem.2006.01.011. [DOI] [Google Scholar]
- 4.Fustero S, Sanz-Cervera J F, Aceña J L, Sánchez-Roselló M. Synlett. 2009:525. doi: 10.1055/s-0028-1087806. [DOI] [Google Scholar]
- 5.Kirk K L. J Fluorine Chem. 2006;127:1013. doi: 10.1016/j.jfluchem.2006.06.007. [DOI] [Google Scholar]
- 6.O’Hagan D. J Fluorine Chem. 2010;131:1071. doi: 10.1016/j.jfluchem.2010.03.003. [DOI] [Google Scholar]
- 7.Bégué J-P, Bonnet-Delpon D. J Fluorine Chem. 2006;127:992. doi: 10.1016/j.jfluchem.2006.05.006. [DOI] [Google Scholar]
- 8.Qiu X-L, Xu X-H, Qing F-L. Tetrahedron. 2010;66:789. doi: 10.1016/j.tet.2009.11.001. [DOI] [Google Scholar]
- 9.Purser S, Moore P R, Swallow S, Gouverneur V. Chem Soc Rev. 2008;37:320. doi: 10.1039/b610213c. [DOI] [PubMed] [Google Scholar]
- 10.Bresciani S, Slawin A M Z, O’Hagan D. J Fluorine Chem. 2009;130:537. doi: 10.1016/j.jfluchem.2009.03.003. [DOI] [Google Scholar]
- 11.Aceña J L, Sorochinsky A E, Soloshonok V A. Synthesis. 2012;44:1591. doi: 10.1055/s-0031-1289756. [DOI] [Google Scholar]
- 12.Lemonnier G, Lion C, Quirion J-C, Pin J-P, Goudet C, Jubault P. Bioorg Med Chem. 2012;20:4716. doi: 10.1016/j.bmc.2012.06.006. [DOI] [PubMed] [Google Scholar]
- 13.Salwiczek M, Nyakatura E K, Gerling U I M, Ye S, Koksch B. Chem Soc Rev. 2012;41:2135. doi: 10.1039/c1cs15241f. [DOI] [PubMed] [Google Scholar]
- 14.Mykhailiuk P K, Shishkina S V, Shishkin O V, Zaporozhets O A, Komarov I V. Tetrahedron. 2011;67:3091. doi: 10.1016/j.tet.2011.02.082. [DOI] [Google Scholar]
- 15.Chia P W, Livesey M R, Slawin A M Z, van Mourik T, Wyllie D J A, O’Hagan D. Chem–Eur J. 2012;18:8813. doi: 10.1002/chem.201200071. [DOI] [PubMed] [Google Scholar]
- 16.Shibata N, Nishimine T, Shibata N, Tokunaga E, Kawada K, Kagawa T, Sorochinsky A E, Soloshonok V A. Chem Commun. 2012;48:4124. doi: 10.1039/c2cc30627a. [DOI] [PubMed] [Google Scholar]
- 17.Smits R, Cadicamo C D, Burger K, Koksch B. Chem Soc Rev. 2008;37:1727. doi: 10.1039/b800310f. [DOI] [PubMed] [Google Scholar]
- 18.Sorochinsky A E, Soloshonok V A. J Fluorine Chem. 2010;131:127. doi: 10.1016/j.jfluchem.2009.09.015. [DOI] [Google Scholar]
- 19.Pan Y, Zhao Y, Ma T, Yang Y, Liu H, Jiang Z, Tan C-H. Chem–Eur J. 2010;16:779. doi: 10.1002/chem.200902830. [DOI] [PubMed] [Google Scholar]
- 20.Acena J L, Simon-Fuentes A, Fustero S. Curr Org Chem. 2010;14:928. doi: 10.2174/138527210791111777. [DOI] [Google Scholar]
- 21.Tarui A, Sato K, Omote M, Kumadaki I, Ando A. Adv Synth Catal. 2010;352:2733. doi: 10.1002/adsc.201000506. [DOI] [Google Scholar]
- 22.Hook D F, Gessier F, Noti C, Kast P, Seebach D. ChemBioChem. 2004;5:691. doi: 10.1002/cbic.200300827. [DOI] [PubMed] [Google Scholar]
- 23.Jäckel C, Koksch B. Eur J Org Chem. 2005:4483. doi: 10.1002/ejoc.200500205. [DOI] [Google Scholar]
- 24.Yoder N C, Kumar K. Chem Soc Rev. 2002;31:335. doi: 10.1039/b201097f. [DOI] [PubMed] [Google Scholar]
- 25.Mathad R I, Jaun B, Flögel O, Gardiner J, Löweneck M, Codée J D C, Seeberger P H, Seebach D, Edmonds M K, Graichen F H M, et al. Helv Chim Acta. 2007;90:2251. doi: 10.1002/hlca.200790235. [DOI] [Google Scholar]
- 26.Capone S, Kieltsch I, Flögel O, Lelais G, Togni A, Seebach D. Helv Chim Acta. 2008;91:2035. doi: 10.1002/hlca.200890217. [DOI] [Google Scholar]
- 27.Fustero S, Sánchez-Roselló M, Rodrigo V, Sanz-Cervera J F, Piera J, Simón-Fuentes A, del Pozo C. Chem–Eur J. 2008;14:7019. doi: 10.1002/chem.200702009. [DOI] [PubMed] [Google Scholar]
- 28.Fustero S, Sánchez-Roselló M, Rodrigo V, del Pozo C, Sanz-Cervera J F, Simón A. Org Lett. 2006;8:4129. doi: 10.1021/ol061733c. [DOI] [PubMed] [Google Scholar]
- 29.Mykhailiuk P K, Radchenko D S, Komarov I V. J Fluorine Chem. 2010;131:221. doi: 10.1016/j.jfluchem.2009.07.017. [DOI] [Google Scholar]
- 30.Pan Y, Calvert K, Silverman R B. Bioorg Med Chem. 2004;12:5719. doi: 10.1016/j.bmc.2004.07.065. [DOI] [PubMed] [Google Scholar]
- 31.Yasuhara A, Sakagami K, Yoshikawa R, Chaki S, Nakamura M, Nakazato A. Bioorg Med Chem. 2006;14:3405. doi: 10.1016/j.bmc.2005.12.061. [DOI] [PubMed] [Google Scholar]
- 32.Wang Z, Silverman R B. Bioorg Med Chem. 2006;14:2242. doi: 10.1016/j.bmc.2005.11.010. [DOI] [PubMed] [Google Scholar]
- 33.Lu H, Silverman R B. J Med Chem. 2006;49:7404. doi: 10.1021/jm0608715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Seebach D, Gardiner J. Acc Chem Res. 2008;41:1366. doi: 10.1021/ar700263g. [DOI] [PubMed] [Google Scholar]
- 35.Seebach D. Angew Chem, Int Ed. 2011;50:96. doi: 10.1002/anie.201003823. [DOI] [PubMed] [Google Scholar]
- 36.Fülöp F. Chem Rev. 2001;101:2181. doi: 10.1021/cr000456z. [DOI] [PubMed] [Google Scholar]
- 37.Kiss L, Forró E, Fülöp F. Synthesis of Carbocyclic β-Amino Acids. In: Hughes A B, editor. Amino Acids, Peptides and Proteins in Organic Chemistry. Vol. 1. Weinheim, Germany: Wiley-VCH; 2009. p. 367. [DOI] [Google Scholar]
- 38.Hameršak Z, Roje M, Avdagić A, Šunjić V. Tetrahedron: Asymmetry. 2007;18:635. doi: 10.1016/j.tetasy.2007.02.019. [DOI] [Google Scholar]
- 39.Rathore N, Gellman S H, de Pablo J J. Biophys J. 2006;91:3425. doi: 10.1529/biophysj.106.084491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Fernandes C, Gauzy C, Yang Y, Roy O, Pereira E, Faure S, Aitken D J. Synthesis. 2007:2222. doi: 10.1055/s-2007-983759. [DOI] [Google Scholar]
- 41.Mowery B P, Lee S E, Kissounko D A, Epand R F, Epand R M, Weisblum B, Stahl S S, Gellman S H. J Am Chem Soc. 2007;129:15474. doi: 10.1021/ja077288d. [DOI] [PubMed] [Google Scholar]
- 42.Gorrea E, Nolis P, Torres E, Da Silva E, Amabilino D B, Branchadell V, Ortuño R M. Chem–Eur J. 2011;17:4588. doi: 10.1002/chem.201002193. [DOI] [PubMed] [Google Scholar]
- 43.Rúa F, Boussert S, Parella T, Díez-Pérez I, Branchadell V, Giralt E, Ortuño R M. Org Lett. 2007;9:3643. doi: 10.1021/ol701521k. [DOI] [PubMed] [Google Scholar]
- 44.Porter E A, Weisblum B, Gellman S H. J Am Chem Soc. 2005;127:11516. doi: 10.1021/ja0519785. [DOI] [PubMed] [Google Scholar]
- 45.Roy O, Faure S, Aitken D J. Tetrahedron Lett. 2006;47:5981. doi: 10.1016/j.tetlet.2006.06.027. [DOI] [Google Scholar]
- 46.D’Elia V, Zwicknagl H, Reiser O. J Org Chem. 2008;73:3262. doi: 10.1021/jo800168h. [DOI] [PubMed] [Google Scholar]
- 47.Hetényi A, Szakonyi Z, Mándity I M, Szolnoki É, Tóth G K, Martinek T A, Fülöp F. Chem Commun. 2009:177. doi: 10.1039/b812114a. [DOI] [PubMed] [Google Scholar]
- 48.Fülöp F, Martinek T A, Tóth G K. Chem Soc Rev. 2006;35:323. doi: 10.1039/b501173f. [DOI] [PubMed] [Google Scholar]
- 49.Torres E, Acosta-Silva C, Rúa F, Álvarez-Larena A, Parella T, Branchadell V, Ortuño R M. Tetrahedron. 2009;65:5669. doi: 10.1016/j.tet.2009.05.039. [DOI] [Google Scholar]
- 50.Farnández D, Torres E, Avilés F X, Ortuño R M, Vendrell J. Bioorg Med Chem. 2009;17:3824. doi: 10.1016/j.bmc.2009.04.035. [DOI] [PubMed] [Google Scholar]
- 51.Fernandes C, Pereira E, Faure S, Aitken D J. J Org Chem. 2009;74:3217. doi: 10.1021/jo900175p. [DOI] [PubMed] [Google Scholar]
- 52.Celis S, Gorrea E, Nolis P, Illa O, Ortuño R M. Org Biomol Chem. 2012;10:861. doi: 10.1039/c1ob06575k. [DOI] [PubMed] [Google Scholar]
- 53.Szolnoki É, Hetényi A, Martinek T A, Szakonyi Z, Fülöp F. Org Biomol Chem. 2012;10:255. doi: 10.1039/c1ob06627g. [DOI] [PubMed] [Google Scholar]
- 54.Martinek T A, Fülöp F. Chem Soc Rev. 2012;41:687. doi: 10.1039/c1cs15097a. [DOI] [PubMed] [Google Scholar]
- 55.Mansawat W, Vilaivan C, Balázs Á, Aitken D J, Vilaivan T. Org Lett. 2012;14:1440. doi: 10.1021/ol300190u. [DOI] [PubMed] [Google Scholar]
- 56.Berlicki Ł, Pilsl L, Wéber E, Mándity I M, Cabrele C, Martinek T A, Fülöp F, Reiser O. Angew Chem, Int Ed. 2012;51:2208. doi: 10.1002/anie.201107702. [DOI] [PubMed] [Google Scholar]
- 57.Kiss L, Forró E, Fülöp F. Tetrahedron. 2012;68:4438. doi: 10.1016/j.tet.2011.12.065. [DOI] [Google Scholar]
- 58.Nonn M, Kiss L, Sillanpää R, Fülöp F. Beilstein J Org Chem. 2012;8:100. doi: 10.3762/bjoc.8.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Kiss L, Forró E, Sillanpää R, Fülöp F. Tetrahedron. 2010;66:3599. doi: 10.1016/j.tet.2010.03.030. [DOI] [Google Scholar]
- 60.Kiss L, Forró E, Martinek T A, Bernáth G, De Kimpe N, Fülöp F. Tetrahedron. 2008;64:5036. doi: 10.1016/j.tet.2008.03.068. [DOI] [Google Scholar]
- 61.Qiu X-L, Qing F-L. Eur J Org Chem. 2011:3261. doi: 10.1002/ejoc.201100032. [DOI] [Google Scholar]
- 62.Mikami K, Fustero S, Sánchez-Roselló M, Aceña J L, Soloshonok V, Sorochinsky A. Synthesis. 2011:3045. doi: 10.1055/s-0030-1260173. [DOI] [Google Scholar]
- 63.Fustero S, Sanz-Cervera J F, Piera J, Sánchez-Roselló M, Chiva G, Simón-Fuentes A. J Fluorine Chem. 2004;125:621. doi: 10.1016/j.jfluchem.2003.12.016. [DOI] [Google Scholar]
- 64.Fustero S, Sánchez-Roselló M, Aceña J L, Fernández B, Asensio A, Sanz-Cervera J F, del Pozo C. J Org Chem. 2009;74:3414. doi: 10.1021/jo900296d. [DOI] [PubMed] [Google Scholar]
- 65.Fustero S, Sánchez-Roselló M, Sanz-Cervera J F, Aceña J L, del Pozo C, Fernández B, Bartolomé A, Asensio A. Org Lett. 2006;8:4633. doi: 10.1021/ol061892w. [DOI] [PubMed] [Google Scholar]
- 66.Mittendorf J, Kunisch F, Matzke M, Militzer H-C, Schmidt A, Schönfeld W. Bioorg Med Chem Lett. 2003;13:433. doi: 10.1016/S0960-894X(02)00958-7. [DOI] [PubMed] [Google Scholar]
- 67.Hamashima Y, Suzuki T, Takano H, Shimura Y, Tsuchiya Y, Moriya K, Goto T, Sodeoka M. Tetrahedron. 2006;62:7168. doi: 10.1016/j.tet.2005.12.070. [DOI] [Google Scholar]
- 68.Kiss L, Forró E, Fustero S, Fülöp F. Eur J Org Chem. 2011:4993. doi: 10.1002/ejoc.201100583. [DOI] [PubMed] [Google Scholar]
- 69.Kiss L, Forró E, Fustero S, Fülöp F. Org Biomol Chem. 2011;9:6528. doi: 10.1039/c1ob05648d. [DOI] [PubMed] [Google Scholar]
- 70.Nonn M, Kiss L, Hänninen M M, Sillanpää R, Fülöp F. Chem Biodiversity. 2012;9:2571. doi: 10.1002/cbdv.201200323. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Experimental procedures and characterization of compounds.